Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gynecologic Tumors”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Early research (Phase 1)Study completedNCT00335998
What this trial is testing

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Who this might be right for
Recurrent Cervical CancerRecurrent Ovarian Epithelial CancerRecurrent Vaginal Cancer+15 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Early research (Phase 1)Study completedNCT02978755
What this trial is testing

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

Who this might be right for
Neoplasm, Gynecologic
GamaMabs Pharma 78
Testing effectiveness (Phase 2)Ended earlyNCT04493619
What this trial is testing

PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

Who this might be right for
Gynecologic NeoplasmsEpithelial Ovarian Cancer
Opna Bio LLC 37
Not applicableLooking for participantsNCT06306170
What this trial is testing

Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

Who this might be right for
Gynecologic CancerRadiotherapy Side EffectRadiotherapy; Complications+3 more
IRCCS San Raffaele 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05787561
What this trial is testing

Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Who this might be right for
Mesonephric Gynecologic Cancer
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 880
Not applicableStudy completedNCT02172638
What this trial is testing

Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management

Who this might be right for
Median Length of StayReadmission RateSurgery Related Complications Rate+1 more
Hospital Universitari Vall d'Hebron Research Institute 110
Not applicableActive Not RecruitingNCT07238023
What this trial is testing

Promoting Active Living Among People With Advanced Cancer

Who this might be right for
Metastatic Invasive Breast CancerMetastatic Invasive Gynecologic Cancer
University of Oklahoma 36
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Ended earlyNCT04527900
What this trial is testing

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Who this might be right for
Endometrial Cancer
University of Maryland, Baltimore 2
Testing effectiveness (Phase 2)Study completedNCT01399658
What this trial is testing

Image-Guided Gynecologic Brachytherapy

Who this might be right for
Cervical CancerUterine CancerVaginal Cancer+1 more
Dana-Farber Cancer Institute 93
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07311538
What this trial is testing

Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies

Who this might be right for
Advanced Gynecological Malignancies
BioRay Pharmaceutical Co., Ltd. 56
Not applicableLooking for participantsNCT05696002
What this trial is testing

Advanced Pelvic Surgical Oncology Database - Prospective Observational Study

Who this might be right for
Rectal CancerPelvic CancerGynecologic Cancer+1 more
Glasgow Royal Infirmary 300
Not applicableUnknownNCT06288854
What this trial is testing

Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer with Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial

Who this might be right for
Weight Gain
Department of Medical Services Ministry of Public Health of Thailand 48
Testing effectiveness (Phase 2)Study completedNCT00390234
What this trial is testing

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Not applicableWithdrawnNCT02470819
What this trial is testing

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast TumorAdvanced Gynecologic Cancer
Avera McKennan Hospital & University Health Center
Early research (Phase 1)Looking for participantsNCT06375187
What this trial is testing

GC203 TIL in Advanced Malignant Solid Tumors

Who this might be right for
Solid TumorGynecologic CancerBreast Cancer+2 more
Shanghai Juncell Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Next Page